Hata S, Shinohara Mayuka, Ando Tadasuke, Mimata Hiromitsu, Shin Toshitaka
Department of Urology, Faculty of Medicine, Oita University, Yufu, JPN.
Cureus. 2024 Jan 22;16(1):e52760. doi: 10.7759/cureus.52760. eCollection 2024 Jan.
We present a first case report of an IL-6-producing pheochromocytoma associated with von Hippel Lindau (vHL) disease. Pheochromocytomas are rare tumors that produce catecholamines, leading to various symptoms. In this case, a 28-year-old woman with a family history of vHL disease presented with a prolonged fever. Laboratory examinations revealed elevated C-reactive protein levels, and notably, a significantly increased serum IL-6 level. Imaging studies confirmed bilateral adrenal tumors with increased uptake on fluorodeoxyglucose-positron emission tomography and I-metaiodobenzylguanidine scintigraphy in the right adrenal gland. Despite partial relief with nonsteroidal anti-inflammatory drugs and alpha-blockers, her fever persisted until prednisolone administration, which promoted a complete resolution. A histopathological analysis following a right laparoscopic adrenalectomy revealed a typical pheochromocytoma. We conducted further analyses, including an enzyme-linked immunosorbent assay (ELISA), a quantitative real-time polymerase chain reaction (PCR) test, and immunoblot assays from the resected tumor tissues. We compared the current case with other cases of pheochromocytoma that presented neither elevated serum IL-6 nor high fever. Using ELISA, we found that this patient exhibited more IL-6 secretion than that seen in other cases. Additionally, quantitative real-time PCR and immunoblot found that both the phosphorylated signal transducer and activator of transcription 3 (STAT3) messenger RNA (mRNA) and protein expression levels exceeded those of the other cases. Thus, we surmised that IL-6 was produced directly from the tumor tissue and IL-6 expression was potentiated through the IL-6/STAT3 signaling pathway. Our findings contribute to the understanding of IL-6-producing pheochromocytomas and their distinct clinical characteristics.
我们报告首例与冯·希佩尔-林道(vHL)病相关的产生白细胞介素-6(IL-6)的嗜铬细胞瘤病例。嗜铬细胞瘤是一种罕见的可产生儿茶酚胺的肿瘤,可导致各种症状。在此病例中,一名有vHL病家族史的28岁女性出现持续发热。实验室检查显示C反应蛋白水平升高,尤其显著的是血清IL-6水平大幅升高。影像学研究证实双侧肾上腺肿瘤,右侧肾上腺在氟脱氧葡萄糖-正电子发射断层扫描及间碘苄胍闪烁扫描中有摄取增加。尽管使用非甾体抗炎药和α受体阻滞剂后症状部分缓解,但她的发热在给予泼尼松龙之前一直持续,给予泼尼松龙后发热完全消退。右侧腹腔镜肾上腺切除术后的组织病理学分析显示为典型的嗜铬细胞瘤。我们对切除的肿瘤组织进行了进一步分析,包括酶联免疫吸附测定(ELISA)、定量实时聚合酶链反应(PCR)检测和免疫印迹分析。我们将本病例与其他既无血清IL-6升高也无高热的嗜铬细胞瘤病例进行了比较。通过ELISA,我们发现该患者的IL-6分泌比其他病例更多。此外,定量实时PCR和免疫印迹发现磷酸化信号转导子和转录激活子3(STAT3)的信使核糖核酸(mRNA)和蛋白表达水平均超过其他病例。因此,我们推测IL-6直接由肿瘤组织产生,且IL-6的表达通过IL-6/STAT3信号通路得到增强。我们的研究结果有助于对产生IL-6的嗜铬细胞瘤及其独特临床特征的理解。